Ticker brief

SNY SANOFI-ADR

Consumer, Non-cyclical · Pharmaceuticals

last close
$44.82
1 day
-0.0%
14 days
+2.5%
mkt cap
$103.3B
signals 14d
6
authors 14d
5
crowd 14d
+0.1σ
Options inteloptions-surface reads · latest available day per source
metricreadingcontext
IV — ATM 30d23% cheap · 12 pctile own 1yIV/HV 0.79×
Skew — 25Δ RR 30d+0.001 89 pctile own 1ycalls bid vs puts (call skew rich)
Net dealer OI (NDOI)-0.01 normal5-session Δ -0.00 (as of 2026-07-06)
OI alarmquietlast alarm 2026-07-10 (z=2.1)
Sentiment — last 14 days
daily mean sentiment, 2026-08-16 → 2026-08-24 · now -0.12 (−1 bearish … +1 bullish)
Who spoke5
authorgradetrader scoresignalsmean sent
@bioinvestor24A-0.452-0.05
@fwpharmaB+0.981-0.15
@DrAhmadAlsabbanC-1.221+0.55
@OracleNYSEC-0.081+0.30
@semodoughC-3.011+0.00
Recent signals6of 6 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-08-24@bioinvestor24-0.25Compares obesity strategies, praising Roche investment but flagging tolerability risks-1.9%
2026-08-24@semodough+0.00Lists Sanofi's August 27 sell-side breakfast with management at 8 a.m. ET.-1.9%
2026-08-19@OracleNYSE+0.30Sanofi and AWS deploy an AI platform targeting faster workflows and reduced wet-lab validation.-2.2%
2026-08-18@DrAhmadAlsabban+0.55Will reconsider buying SNY a third time if it falls below $43. — After detailing two completed trades, author states a conditional plan to buy SNY again below $43.-0.3%
2026-08-17@fwpharma-0.15Reports Sanofi staff reductions following its Blueprint transaction.+0.9%
2026-08-16@bioinvestor24+0.15Questions KYMR's valuation, differentiation and development timeline while comparing peers and FOMO.+2.5%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.